FDA Puts the Brakes on Roche's Gene Array Test
Explore this paper's citation graph
Summary
The U.S. government has blocked the sale of a new kind of DNA diagnostic test, putting up an unexpected barrier to the marketing of technology to distinguish genetic differences in how patients metabolize certain drugs.
- Type
- article
- Published
- 2003-11-14
- Cited by
- 3
- References
- 0
- OpenAlex
- https://openalex.org/W1492825341
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:27570461
Keywords
Test (biology), Gene, Biology, Computational biology, Genetics
References
No references recorded for this paper.
Cited by
Related papers
- Cloning and Characterization of Rat BAT3 cDNA
- HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
- Anthoxanthum Mosaic Virus
- Ecological and evolutionary importance of neighbors in the grass Anthoxanthum odoratum
- HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice
- Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis
- Viral Pathogens and the Advantage of Sex in the Perennial Grass Anthoxanthum odoratum [and Discussion]
- ON THE LIFE‐HISTORY OF “WIREWORMS” OF THE GENUS AGRIOTES ESCH.: PART IV.
- Expression of two soybean resistance gene candidates shows divergence of paralogous single-copy genes